investments ABBOTT INDIA is immune from the US tariff woes & can sustain the ROCE of 45%. Buy for target price of ₹40128 (16% upside): BOB Caps Arjun July 12, 2025 0 Abbott’s core portfolio productivity is the highest in the industry — at Rs 12.5mn...Read More
